tem
|
SR6604
|
SR6608
|
|
Chassis
|
Integrated chassis, which can be installed in a 19-inch rack. Distributed service architecture.
|
Integrated chassis, which can be installed in a 19-inch rack. Distributed service architecture.
|
|
MPU slots
|
2 (1+1 redundancy)
|
2 (1+1 redundancy)
|
|
Maximum FIP modules
|
2
|
4
|
|
IP Forwarding Performance (IMIX)
|
FIP-260: 34Gbps
FIP-380: 40Gbps FIP-660: 80Gbps SAP-XP4GE32: 40Gbps |
|
|
Forwarding Performance with ACL+NAT+QOS (IMIX)
|
FIP-260: 15Gbps
FIP-380: 20Gbps FIP-660: 60Gbps SAP-XP4GE32: 20Gbps |
|
|
IPSec Forwarding Performance (1400byte)
|
FIP-260:10Gbps
FIP-380: 14bps FIP-660: 35Gbps SAP-XP4GE32: 12Gbps |
|
|
IPSec tunnel
|
RPE-X5E: 50,000
RPE-X5: 50,000 RPE-X3: 10,000 |
|
|
Power module
|
1+1 redundancy
650W/1200W |
1+1 redundancy
650W/1200W |
|
Rated AC power
|
100 to 240 VAC @ 50 Hz/60 Hz
|
100 to 240 VAC @ 50 Hz/60 Hz
|
|
Rated DC power
|
–48 to –60 VDC
|
–48 to –60 VDC
|
|
Operating temperature
|
0ºC to 45ºC (32°F to 113°F)
|
0ºC to 45ºC (32°F to 113°F)
|
|
Operating humidity
|
5% RH to 95% RH, non-condensing
|
5% RH to 95% RH, non-condensing
|
|
Operating altitude
|
–60 to +5000 m (–196.85 to +16404.20 ft)
|
–60 to +5000 m (–196.85 to +16404.20 ft)
|
|
Size
|
436mm×480mm×220mm(5U)
|
436mm×480mm×308mm(7U)
|
|
MTBF
|
31.19 years
|
26.8 years
|
|
MTTR
|
1 hour
|
1 hour
|
|
EMC
|
FCC Part 15 (CFR 47) CLASS A
ICES-003 CLASS A VCCI CISPR32 CLASS A CISPR 32 CLASS A EN 55032 CLASS A AS/NZS CISPR32 CLASS A CISPR 24 EN 55024 EN 61000-3-2 EN 61000-3-3 EN 61000-6-1 ETSI EN 300 386 EN 301 489-1 EN 301 489-17 |
FCC Part 15 (CFR 47) CLASS A
ICES-003 CLASS A VCCI CISPR32 CLASS A CISPR 32 CLASS A EN 55032 CLASS A AS/NZS CISPR32 CLASS A CISPR 24 EN 55024 EN 61000-3-2 EN 61000-3-3 EN 61000-6-1 ETSI EN 300 386 EN 301 489-1 EN 301 489-17 |
|
Security
|
UL 60950-1
CAN/CSA C22.2 No 60950-1 IEC 60950-1 EN 60950-1/A11 AS/NZS 60950 EN 60825-1 EN 60825-2 FDA 21 CFR Subchapter J GB 4943 |
UL 60950-1
CAN/CSA C22.2 No 60950-1 IEC 60950-1 EN 60950-1/A11 AS/NZS 60950 EN 60825-1 EN 60825-2 FDA 21 CFR Subchapter J GB 4943 |
Email: Lilicheng0510@163.com